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Purpose: Investigation of the potential of casein micellar formulations as drug vehicles in pediatrics. 
Methods: Several casein (CN) formulations were prepared, by the addition of cryoprotectant (mannitol 
or lactose, 1%w/v), crosslinker carbodiimide (EDC, 0.03M, during 24h) or genipin (GP, 0.03M, during 
24h) and/or paracetamol (PC). The dispersions were freeze (-80°C/24h)-dried (-50°C/0.035mbar/12h) 
(FD) and stored at room temperature (3month). Micelles were characterized for shape (TEM), particle 
size, zeta potential and encapsulation efficiency (EE). FTIR spectra (4000–400cm
−1
) and thermograms 
(15-200°C) were obtained. The release of PC from uncrosslinked and crosslinked micelles was compared 
in phosphate buffered saline (PBS) pH 7.4. PC was quantified by liquid chromatography (phosphate 
buffer, 0.01M NaH2PO4/pH5.8 and acetonitrile gradient).  
Results and Discussion: Crosslinking promoted more compact micellar structure for CN-EDC (80±13nm) 
but larger micellar size (205±8nm) for CN-GP compared to control CN samples (178±22nm). The addition 
of cryoprotectant resulted in small micelles (80-90nm), whereas PC loaded micelles increased the 
average micellar size after FD. The EE was approximately 30% and remained stable during FD in 
uncrosslinked casein, but dropped down to 14% in FD GP-CN samples. All micelles presented a negative 
surface charge (-5 to – 8 mV). Thermograms of casein failed to show thermal events and PC was not 
detectable in the CN micelles due to the absence of an endotherm (169°C, form I), suggesting its 
existence in the amorphous state. The second derivative spectra of crosslinked CN displayed altered 
stretching frequencies and peak shifts, compared to uncrosslinked casein, in the amide II and III region 
which could be attributed to potential intramolecular cross-linking. Significantly retarded release was 
found for the PC entrapped into the casein micelles, particularly the ones with EDC and lactose, as 
compared to the free drug control. All micelles were stable over 3 months of storage, except for GP 
crosslinked samples. 
Conclusions: Casein can be a vehicle for the delivery of drugs in pediatrics, following a straightforward 
production process, namely with retarded release of the encapsulated drug. Furthermore the study also 
provided information on the use of carbodiimide as a crosslinker for casein. 
 
